Literature DB >> 8815562

Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease.

D Mari1, L Parnetti, R Coppola, B Bottasso, G P Reboldi, U Senin, P M Mannucci.   

Abstract

Since it has not been established to what extent abnormalities of hemostasis contribute to the occurrence and development of dementia, selected measurements of coagulation and fibrinolysis were obtained in elderly patients with Alzheimer's disease (n = 22) or vascular dementia (n = 29), compared with healthy individuals in the same age range (n = 61). Hemostasis abnormalities were more frequent and marked in vascular dementia, being expressed as significant increases of plasminogen activator inhibitor type 1, von Willebrand factor, D-dimer and activated factor VII. However, some hemostasis measurements (von Willebrand factor, activated factor VII) were abnormally high also in the patients with Alzheimer's disease, a condition in which vascular damage is not considered to play a major pathogenetic role. It could not be established in this study whether or not these hemostatic abnormalities play a casual role in the pathogenesis of dementia, or whether they are secondary to inflammation and chronic vascular disease. Nevertheless, their presence may contribute to aggravating vascular disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815562

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice.

Authors:  Zu-Lin Chen; Alexey S Revenko; Pradeep Singh; A Robert MacLeod; Erin H Norris; Sidney Strickland
Journal:  Blood       Date:  2017-02-27       Impact factor: 22.113

Review 2.  Tissue plasminogen activator in central nervous system physiology and pathology.

Authors:  Jerry P Melchor; Sidney Strickland
Journal:  Thromb Haemost       Date:  2005-04       Impact factor: 5.249

3.  Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets.

Authors:  Tyler A Kokjohn; Gregory D Van Vickle; Chera L Maarouf; Walter M Kalback; Jesse M Hunter; Ian D Daugs; Dean C Luehrs; John Lopez; Daniel Brune; Lucia I Sue; Thomas G Beach; Eduardo M Castaño; Alex E Roher
Journal:  Biochim Biophys Acta       Date:  2011-07-20

Review 4.  Fibrinogen and altered hemostasis in Alzheimer's disease.

Authors:  Marta Cortes-Canteli; Daria Zamolodchikov; Hyung Jin Ahn; Sidney Strickland; Erin H Norris
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 5.  Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Authors:  Geetika Nehra; Bjoern Bauer; Anika M S Hartz
Journal:  Pharmacol Ther       Date:  2022-01-30       Impact factor: 13.400

6.  Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside-Containing Nanoliposomes.

Authors:  Nina Karamanova; Seth Truran; Geidy E Serrano; Thomas G Beach; Jillian Madine; Volkmar Weissig; Hannah A Davies; Jaimeson Veldhuizen; Mehdi Nikkhah; Michael Hansen; Weiyang Zhang; Karen D'Souza; Daniel A Franco; Raymond Q Migrino
Journal:  J Am Heart Assoc       Date:  2020-01-13       Impact factor: 5.501

7.  Plasma contact factors as novel biomarkers for diagnosing Alzheimer's disease.

Authors:  Jung Eun Park; Do Sung Lim; Yeong Hee Cho; Kyu Yeong Choi; Jang Jae Lee; Byeong C Kim; Kun Ho Lee; Jung Sup Lee
Journal:  Biomark Res       Date:  2021-01-09

8.  Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study.

Authors:  Soo Chan Carusone; Marek Smieja; William Molloy; Charlie H Goldsmith; Jim Mahony; Max Chernesky; Judy Gnarpe; Tim Standish; Stephanie Smith; Mark Loeb
Journal:  BMC Neurol       Date:  2004-10-12       Impact factor: 2.474

9.  Deficiency of tPA Exacerbates White Matter Damage, Neuroinflammation, Glymphatic Dysfunction and Cognitive Dysfunction in Aging Mice.

Authors:  Peng Yu; Poornima Venkat; Michael Chopp; Alex Zacharek; Yi Shen; Linlin Liang; Julie Landschoot-Ward; Zhongwu Liu; Rongcai Jiang; Jieli Chen
Journal:  Aging Dis       Date:  2019-08-01       Impact factor: 6.745

10.  Deep phenotyping of Alzheimer's disease leveraging electronic medical records identifies sex-specific clinical associations.

Authors:  Alice S Tang; Tomiko Oskotsky; Shreyas Havaldar; William G Mantyh; Mesude Bicak; Caroline Warly Solsberg; Sarah Woldemariam; Billy Zeng; Zicheng Hu; Boris Oskotsky; Dena Dubal; Isabel E Allen; Benjamin S Glicksberg; Marina Sirota
Journal:  Nat Commun       Date:  2022-02-03       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.